Home Current Issue Previous Issues Published Ahead-of-Print CME Blog For Authors Journal Info
Skip Navigation LinksHome > Published Ahead-of-Print > Olanzapine-Induced Eccrine Squamous Syringometaplasia
You could be reading the full-text of this article now...
If you have access to this article through your institution, you can view this article in OvidSP.
American Journal of Dermatopathology:
POST AUTHOR CORRECTIONS, 16 January 2012
doi: 10.1097/DAD.0b013e31823812f1
Brief Report: PDF Only

Olanzapine-Induced Eccrine Squamous Syringometaplasia

Molina-Ruiz, Ana María MD; Molina-Ruiz, Rosa Maria MD; Zulueta, Teresa MD; Barabash, Román MD; Requena, Luis MD

Published Ahead-of-Print
Collapse Box

Abstract

Eccrine squamous syringometaplasia is a histopathologic pattern that has mainly been described in patients receiving chemotherapy. Its association to nonchemotherapeutic agents is rare, with very few cases reported in the literature. We present the case of a 55-year-old patient with schizophrenia, who developed a skin eruption 5 weeks after initiating treatment with olanzapine. The histopathologic study revealed squamous syringometaplasia of the dermal eccrine ducts.

(C) 2012 Lippincott Williams & Wilkins, Inc.

Login




Help

Forgot Password?

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.